Literature DB >> 7272599

The effects of morphine and methionine-enkephalin on the release of purines from cerebral cortex slices of rats and mice.

T W Stone.   

Abstract

1 Slices of cerebral cortex from Wistar rats, TO mice or C57 mice were preincubated with [3H]-adenosine, and labelled purines were subsequently releases by electrical stimulation or by perfusing with ouabain, 100 micro M. 2 Electrically-evoked purine release was substantially reduced when the Ca2+ concentration in the medium was lowered from 2.4 to 0.1 mM. In both rats and mice, the electrically-evoked release was increased by morphine and methionine-enkephalin (Met-enkephalin), 10 micro M, and in rats and TO mice by morphine 1 micro M, both drug effects being prevented by naloxone. 3 Purine release evoked by ouabain was also increased by morphine 1 and 10 micro M, though not by Met-enkephalin, from slices of rat cortex. Ouabain-induced release from TO mice was reduced by morphine, and from C57 mice was unchanged. 4 The enhancement by morphine of electrically-evoked purine release may indicate that purines mediate some effects of morphine in the CNS.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7272599      PMCID: PMC2071872          DOI: 10.1111/j.1476-5381.1981.tb09970.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

1.  Morphone abstinence and quasi-abstinence effects after phosphodiesterase inhibitors and naloxone.

Authors:  D L Francis; A C Roy; H O Collier
Journal:  Life Sci       Date:  1975-06-15       Impact factor: 5.037

2.  Interactions of morphine, adenosine, adenosine triphosphate and phosphodiesterase inhibitors on the field-stimulated guinea-pig ileum.

Authors:  A R Gintzler; J M Musacchio
Journal:  J Pharmacol Exp Ther       Date:  1975-09       Impact factor: 4.030

3.  Quasi morphine-abstinence syndrome.

Authors:  H O Collier; D L Francis; G Henderson; C Schneider
Journal:  Nature       Date:  1974-05-31       Impact factor: 49.962

4.  Effects of morphine on kinetics of 14C-dopamine in rat striatal slices.

Authors:  B Celsen; K Kuschinsky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

5.  A new example of a morphine-sensitive neuro-effector junction: adrenergic transmission in the mouse vas deferens.

Authors:  G Henderson; J Hughes; H W Kosterlitz
Journal:  Br J Pharmacol       Date:  1972-12       Impact factor: 8.739

6.  Morphine catalepsy in the rat: relation to striatal dopamine metabolism.

Authors:  K Kuschinsky; O Hornykiewicz
Journal:  Eur J Pharmacol       Date:  1972-07       Impact factor: 4.432

Review 7.  Regulatory significance of the release and action of adenine derivatives in cerebral systems.

Authors:  H McIlwain
Journal:  Biochem Soc Symp       Date:  1972

8.  The effect of adenosine on the release of the transmitter from the phrenic nerve of the rat.

Authors:  B L Ginsborg; G D Hirst
Journal:  J Physiol       Date:  1972-08       Impact factor: 5.182

9.  Output of (14C)adenine nucleotides and their derivatives from cerebral tissues. Tetrodotoxin-resistant and calcium ion-requiring components.

Authors:  I Pull; H McIlwain
Journal:  Biochem J       Date:  1973-12       Impact factor: 3.857

10.  Stimulated formation of adenosine 3',5'-cyclic phosphate in cerebral cortex: synergism between electrical activity and biogenic amines.

Authors:  H Shimizu; C R Creveling; J Daly
Journal:  Proc Natl Acad Sci U S A       Date:  1970-04       Impact factor: 11.205

View more
  7 in total

1.  Quantitative autoradiography of adenosine receptors in brains of chronic naltrexone-treated mice.

Authors:  Alexis Bailey; Rachel M Hawkins; Susanna M O Hourani; Ian Kitchen
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

Review 2.  Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry implications for drug addiction, sleep and pain.

Authors:  S Ferré; I Diamond; S R Goldberg; L Yao; S M O Hourani; Z L Huang; Y Urade; I Kitchen
Journal:  Prog Neurobiol       Date:  2007-05-01       Impact factor: 11.685

Review 3.  Release and actions of adenosine in the central nervous system.

Authors:  M J Higgins; H Hosseinzadeh; D G MacGregor; H Ogilvy; T W Stone
Journal:  Pharm World Sci       Date:  1994-04-15

4.  Antagonism of enkephalin action on acetylcholine release by methylxanthines: lack of a purine link.

Authors:  J Elliott; K Jhamandas; H Notman; M Sutak
Journal:  Br J Pharmacol       Date:  1983-12       Impact factor: 8.739

5.  Cyclic nucleotides and aminophylline produce different effects on nociceptive motor and sensory responses in the rat spinal cord.

Authors:  I Jurna
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-08       Impact factor: 3.000

6.  Uliginosin B, a Possible New Analgesic Drug, Acts by Modulating the Adenosinergic System.

Authors:  Eveline Dischkaln Stolz; Paola Fontoura da Costa; Liciane Fernandes Medeiros; Andressa Souza; Ana Maria Oliveira Battastini; Gilsane Lino von Poser; Carla Bonan; Iraci L S Torres; Stela Maris Kuze Rates
Journal:  Evid Based Complement Alternat Med       Date:  2016-03-21       Impact factor: 2.629

Review 7.  The Role of Adenosine Receptors in Psychostimulant Addiction.

Authors:  Inmaculada Ballesteros-Yáñez; Carlos A Castillo; Stefania Merighi; Stefania Gessi
Journal:  Front Pharmacol       Date:  2018-01-10       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.